Madrigal Pharmaceuticals, Inc. Common Stock
MDGL
MDGL: Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
moreShow MDGL Financials
Recent trades of MDGL by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Daniel Goldman House / D | Sale $1,001 - $15,000 | Apr. 10, 2023 |
Recently reported changes by institutional investors
Quarterly net insider trading by MDGL's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Methods of synthesizing thyroid hormone analogs and polymorphs thereof Jan. 31, 2023
-
Patent Title: Combination therapies comprising targeted therapeutics Nov. 08, 2022
-
Patent Title: Targeted therapeutics Jul. 05, 2022
-
Patent Title: Methods of treating liver disorders or lipid disorders with a thr-beta agonist Aug. 17, 2021
-
Patent Title: Methods of synthesizing thyroid hormone analogs and polymorphs thereof Jan. 19, 2021
-
Patent Title: Targeted therapeutics Nov. 10, 2020
-
Patent Title: Targeted therapeutics Jul. 28, 2020
-
Patent Title: Targeted therapeutics Jun. 09, 2020
-
Patent Title: Targeted therapeutics Aug. 13, 2019
-
Patent Title: Methods of synthesizing thyroid hormone analogs and polymorphs thereof Aug. 13, 2019
-
Patent Title: Targeted therapeutics Mar. 19, 2019
-
Patent Title: Targeted therapeutics Nov. 06, 2018
-
Patent Title: Method of synthesizing thyroid hormone analogs and polymorphs thereof May. 15, 2018
-
Patent Title: Targeted therapeutics May. 01, 2018
-
Patent Title: Compositions and methods for modulating c-rel-dependent cytokine production Mar. 06, 2018
-
Patent Title: Method of synthesizing thyroid hormone analogs and polymorphs thereof Feb. 23, 2016
-
Patent Title: Diacylglycerol acyltransferase inhibitors Dec. 04, 2012
-
Patent Title: Inhibitors of diacylglycerol acyltransferase Jul. 03, 2012
-
Patent Title: Diacylglycerol acyltransferase inhibitors Jul. 03, 2012
-
Patent Title: Diacylglycerol acyltransferase inhibitors Apr. 10, 2012
-
Patent Title: Inhibitors of diacylglycerol acyltransferase Feb. 28, 2012
-
Patent Title: Diacylglycerol acyltransferase inhibitors Feb. 14, 2012
Federal grants, loans, and purchases
Followers on MDGL's company Twitter account
Number of mentions of MDGL in WallStreetBets Daily Discussion
Recent insights relating to MDGL
Recent picks made for MDGL stock on CNBC
ETFs with the largest estimated holdings in MDGL
Flights by private jets registered to MDGL